• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Metformin linked to decreased BMI z scores in prepubertal children

byMatthew Lin, MDandCordelia Ross
June 12, 2017
in Chronic Disease, Endocrinology, Pediatrics, Public Health
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Prepubertal obese children treated with metformin over 6 months had significantly lower BMI z scores compared to those receiving placebo. These differences were not present in pubertal children.

2. Prepubertal obese children treated with metformin over 6 months had higher qualitative insulin-sensitivity check index (QUICKI), or lower rates of insulin resistance, compared to those receiving placebo. Additionally, prepubertal obese children had lower concentrations of INF-gamma and tPAI-1 at 6 months compared to prepubertal children on placebo.

Evidence Rating: 1 (Excellent)

Study Rundown: Obesity and diabetes are an increasing problem in the pediatric population. Metformin is an established oral antihyperglycemic agent approved for the treatment of adults with type 2 diabetes mellitus and in children >10 years of age. In adults, metformin has been shown to significantly reduce obesity. Similar existing trials in pediatric patients have not taken into consideration the stages of puberty as a confounding factor in the effects of metformin on weight loss. In this study, researchers investigated whether treatment with oral metformin is capable of reducing BMI z score, insulin sensitivity and inflammatory biomarkers in obese children, while stratifying for pubertal stage by Tanner staging. Researchers found an exclusive significant decrease in BMI z score in prepubertal children in the metformin group compared to the placebo group at 6 months. Additionally, prepubertal children in the metformin group had significantly lower scores of insulin resistance and lower concentrations of pro-inflammatory markers, including INF-gamma and tPAI-1. The authors suggest that the lack of significant results observed in the pubertal group may be due to the well-known decrease in insulin sensitivity known to occur in this population. Limitations of the study include medication compliance assessment by pill bottle return, as opposed to pill counting, and difficulty in assessing the effects of lifestyle changes in the children throughout the study. These results suggest that while metformin offers several metabolic benefits in prepubertal children, puberty itself may impact the extent of these effects.

Click to read the study, published today in Pediatrics

Relevant Reading: Metformin and body weight

RELATED REPORTS

Prognostic associations of anthropometric indices vary by clinical outcomes

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

FDA approvedFor obesity: Foundayo (orforglipron), Apr 1, 2026→

In-Depth [randomized controlled trial]: Participants in this randomized, double-blind, placebo-control trial included 140 children (82 boys, 68 girls) across 4 Spanish hospitals. The primary outcome was BMI z score compared to baseline after 6 months. Secondary outcomes included insulin resistance and concentrations of inflammatory markers. In the prepubertal population, BMI z scores were significantly decreased in the metformin group when compared to placebo (P = 0.04). Baseline and 6 month BMI z scores were 4.0 ± 0.2 and 3.4 ± 0.2 for the placebo group, and 3.4 ± 0.2 and 2.6 ± 0.20 for the metformin group. Such significant differences were not observed in the pubertal group. Additionally, binary logistic regression showed an independent association between BMI z score and metformin treatment (OR = 0.18 [95% CI = 0.050-0.636; P = 0.01]. Insulin sensitivity was determined using the Qualitative insulin-sensitivity check index (QUICKI) – a measure of insulin resistance based on fasting glucose and insulin levels, with lower levels indicating resistance. Prepubertal children in the metformin group had significantly increased QUICKI scores compared to those receiving placebo (P = 0.01). No significant differences were seen in the pubertal group. Of the inflammatory markers tested, prepubertal children had lower concentrations of INF-gamma (P = 0.02) and tPAI-1 (P = 0.04). Again, these significant differences were not seen in pubertal children.

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: BMIchildhood obesitymetformin
Previous Post

Next-generation metagenomics sequencing may sleuth out hard-to-find viruses in the blood

Next Post

Tofacitinib may be an effective treatment for nail psoriasis

RelatedReports

An illustration featuring a heart within a house, with a stethoscope, a scale, and medication, symbolizing heart failure home hospital care.
Cardiology

Prognostic associations of anthropometric indices vary by clinical outcomes

September 28, 2026
Weight loss collage: a smiling bearded man in an open-collared shirt beside a coiled leather belt and a plate of salad greens
Endocrinology

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

August 31, 2026
Diabetes collage: a lidded sugar bowl inside a blue paper circle, with a whole apple and a bunch of leafy greens
Chronic Disease

Intermittent metformin (Glucophage) is non-inferior to continuous metformin for prediabetes in post-partum women with prior gestational diabetes mellitus

July 21, 2026
Weight management collage: a smiling middle-aged woman in a collared blouse beside a pear, a mint sprig and a coiled belt
Chronic Disease

Sleep restriction promotes weight gain in high-risk adults 

July 6, 2026
Next Post
Long-term use of apremilast for psoriasis associated with an acceptable safety profile

Tofacitinib may be an effective treatment for nail psoriasis

Lithium during pregnancy linked to modest increase in cardiac malformations

Women with pregnancy-associated melanoma at greater risk of metastasis, recurrence

Complete dissection does not increase survival for sentinel-node positive melanoma patients

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality
  • In a phase 3 trial, tirzepatide reduced BMI versus placebo in adolescents with obesity and obesity-related complications
  • Continuation of immunotherapy after immune checkpoint inhibitor-induced myocarditis in patients with lung cancer may be safe and effective
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.